On September 25, 2025, NKGen Biotech, Inc. entered into a consulting agreement with Dr. Yong Man Kim, allowing him to continue as Chief Scientific Officer in a consulting role while accommodating his new position as President of NKMax. This change was effective from September 10, 2025, and is significant for the company's ongoing research and development efforts.